查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1543928

髓內輸液設備的全球市場

Intraosseous Infusion Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年全球髓內輸液設備市場規模將達82億美元

2023年全球髓內輸液設備市場估計為54億美元，預計到2030年將達82億美元，2023年至2030年複合年成長率為6.3%。自動化技術是本報告分析的細分市場之一，預計複合年成長率為 7.5%，到分析期結束時將達到 56 億美元。分析期間內，手動技術領域的複合年成長率預計為 4.3%。

美國市場預計15億美元，中國預計複合年成長率5.8%

預計2023年美國髓內輸液設備市場規模將達15億美元。中國作為世界第二大經濟體，預計2030年市場規模將達13億美元，2023-2030年分析期間複合年成長率為5.8%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 6.1% 和 4.9%。在歐洲，德國預計複合年成長率為 5.0%。

全球髓內輸液設備市場 - 主要趨勢與促進因素總結

什麼是髓內輸液設備？

髓內輸液設備是一種專門的醫療裝置，設計用於在無法進行傳統靜脈 (IV) 注射時將液體、藥物和血液製品直接注射到骨髓。這些設備在急救醫學中至關重要，特別是在創傷、心臟麻痹和休克等時間敏感的情況下，患者可能患有靜脈塌陷或其他難以進入靜脈的情況。靜脈輸注提供了一種快速、可靠且有效的血管通路替代方案，可以快速提供挽救生命的治療。此類設備的使用正在增加，特別是在急診室、加護病房和軍隊等環境中，在這些環境中，即時血管通路對患者的治療結果有重大影響。

技術進步如何形塑髓內輸液設備市場？

技術進步在塑造髓內輸液設備市場方面發揮關鍵作用，特別是設備設計、易用性和安全功能的創新。現代骨內裝置擴大設計為自動或半自動部署，從而減少了插入所需的技能並最大限度地降低了併發症的風險。這些設備現在通常包括安全機制，以防止針刺傷害並確保安全放置在骨髓內。此外，材料和工程的進步促進了更耐用、更可靠的儀器的開發，這些儀器可以承受緊急情況下的嚴酷使用。這些創新使更廣泛的醫療保健提供者更容易使用髓內注射，並擴大其在院前、醫院和軍事環境中的使用。

為什麼醫療機構對髓內輸液設備的需求不斷增加？

由於人們越來越認知到髓內輸液設備在重症加護中的有效性以及擴大醫療保健專業人員的培訓計劃，醫療機構對髓內輸液裝置的需求正在增加。隨著越來越多的醫療保健提供者（包括護理人員、急診醫生和軍醫）接受腹膜內裝置使用培訓，它的採用變得越來越廣泛。該設備在必須快速進入循環系統的情況下尤其有價值，例如在急診室或轉運重症患者期間。此外，可導致血管併發症的慢性疾病和病症的流行增加了對替代血管通路方法的需求，進一步推動了對髓內輸液設備的需求。這些設備的採用也得到了最新的臨床指南和協議的支持，通訊協定建議在特定的緊急情況下使用它們，從而加強了它們在現代醫療實踐中的作用。

推動髓內輸液設備市場成長的因素有哪些？

髓內輸液設備市場的成長是由與技術進步、應用範圍擴大以及重症加護中快速血管通路日益成長的需求密切相關的幾個因素所推動的。主要促進因素之一是設備設計的進步，這使得腹膜內注射變得更容易、更安全、更可靠。這導致其在各種醫療機構中廣泛採用，包括急診、加護病房和院前護理。創傷、心臟緊急情況和其他需要立即血管通路的情況的發生率不斷上升，也使得這些設備成為傳統靜脈通路困難時的快速有效的替代品，這推動了市場的成長。此外，越來越注重改善緊急情況下的患者治療效果以及增加醫療保健專業人員的培訓機會也正在推動市場向前發展。隨著這些趨勢的不斷發展，在對先進、可靠和快速血管通路解決方案的重症加護需求的推動下，髓內輸液設備市場預計將持續成長。

受訪企業範例（共42例）

  • Aero Healthcare
  • Becton, Dickinson and Company
  • Biopsybell Srl
  • Cook Medical, Inc.
  • PAVmed, Inc.
  • PerSys Medical
  • Pyng Medical
  • Teleflex, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP12828

Global Intraosseous Infusion Devices Market to Reach US$8.2 Billion by 2030

The global market for Intraosseous Infusion Devices estimated at US$5.4 Billion in the year 2023, is expected to reach US$8.2 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2023-2030. Automatic Technology, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$5.6 Billion by the end of the analysis period. Growth in the Manual Technology segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 5.8% CAGR

The Intraosseous Infusion Devices market in the U.S. is estimated at US$1.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 5.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.1% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Global Intraosseous Infusion Devices Market - Key Trends & Drivers Summarized

What Are Intraosseous Infusion Devices and Why Are They Critical in Emergency Medical Care?

Intraosseous infusion devices are specialized medical tools designed to deliver fluids, medications, and blood products directly into the bone marrow when traditional intravenous (IV) access is not feasible. These devices are critical in emergency medical care, particularly in situations where time is of the essence, such as during trauma, cardiac arrest, or shock, where patients may have collapsed veins or other conditions that make IV access difficult. Intraosseous infusion provides a rapid, reliable, and effective alternative for vascular access, ensuring that lifesaving treatments can be administered quickly. The use of these devices is growing, especially in emergency rooms, intensive care units, and military settings, where immediate vascular access can significantly impact patient outcomes.

How Are Technological Advancements Shaping the Intraosseous Infusion Devices Market?

Technological advancements are playing a significant role in shaping the intraosseous infusion devices market, particularly through innovations in device design, ease of use, and safety features. Modern intraosseous devices are increasingly being designed for automatic or semi-automatic deployment, which reduces the skill level required for insertion and minimizes the risk of complications. These devices now often feature safety mechanisms to prevent needle-stick injuries and to ensure secure placement within the bone marrow. Additionally, advancements in materials and engineering have led to the development of more durable and reliable devices that can withstand the rigors of emergency use. These innovations are making intraosseous infusion more accessible to a broader range of healthcare providers, thereby expanding its use in pre-hospital, hospital, and military environments.

Why Is There an Increasing Demand for Intraosseous Infusion Devices Across Healthcare Settings?

The demand for intraosseous infusion devices is increasing across healthcare settings due to the growing recognition of their effectiveness in critical care situations and the expanding training programs for healthcare professionals. As more healthcare providers, including paramedics, emergency physicians, and military medics, are trained in the use of intraosseous devices, their adoption is becoming more widespread. The devices are particularly valued in settings where rapid access to the circulatory system is essential, such as in emergency rooms and during transport of critically ill patients. Additionally, the increasing prevalence of chronic diseases and conditions that can lead to vascular complications is driving the need for alternative vascular access methods, further boosting demand for intraosseous infusion devices. The adoption of these devices is also supported by updated clinical guidelines and protocols that recommend their use in specific emergency situations, reinforcing their role in modern medical practice.

What Factors Are Driving the Growth in the Intraosseous Infusion Devices Market?

The growth in the intraosseous infusion devices market is driven by several factors closely tied to technological advancements, expanding applications, and the increasing need for rapid vascular access in critical care. One of the primary drivers is the advancement in device design, which has made intraosseous infusion easier to perform, safer, and more reliable. This has led to broader adoption across various healthcare settings, including emergency departments, intensive care units, and pre-hospital care. The rising incidence of trauma, cardiac emergencies, and other conditions requiring immediate vascular access is also fueling market growth, as these devices offer a fast and effective alternative when traditional IV access is challenging. Additionally, the growing focus on improving patient outcomes in emergency situations, along with the increasing availability of training for healthcare professionals, is driving the market forward. As these trends continue to evolve, the intraosseous infusion devices market is expected to experience sustained growth, driven by the need for advanced, reliable, and rapid vascular access solutions in critical care scenarios.

Select Competitors (Total 42 Featured) -

  • Aero Healthcare
  • Becton, Dickinson and Company
  • Biopsybell Srl
  • Cook Medical, Inc.
  • PAVmed, Inc.
  • PerSys Medical
  • Pyng Medical
  • Teleflex, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Intraosseous Infusion Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Rapid Access in Emergency Medicine Spurs Adoption of Intraosseous Infusion Devices
    • Advancements in Device Technology Propel Innovation in Intraosseous Infusion
    • Shift Towards Minimally Invasive Emergency Procedures Expands Market Opportunities
    • Increasing Adoption of Intraosseous Infusion in Pediatric and Geriatric Patients
    • Role of Intraosseous Devices in Military and Disaster Medicine
    • Growing Importance of Immediate Vascular Access in Critical Care
    • Expansion of Pre-Hospital Care Drives Demand for Portable Intraosseous Devices
    • Emerging Markets Present New Opportunities for Intraosseous Device Manufacturers
    • Push for Cost-Effective and Easy-to-Use Infusion Solutions
    • Role of Intraosseous Devices in Enhancing Survival Rates in Trauma Cases
    • Integration of Intraosseous Infusion Devices with Advanced Monitoring Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Sternum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Sternum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Sternum by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Distal & Proximal Tibia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Distal & Proximal Tibia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Distal & Proximal Tibia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Distal Femur by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Distal Femur by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Distal Femur by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Calcaneus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Calcaneus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Calcaneus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Head of Humerus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Head of Humerus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Head of Humerus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Automatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Automatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Automatic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Manual by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Manual by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Manual by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for EMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for EMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for EMS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Cardiac Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Cardiac Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 33: World 16-Year Perspective for Cardiac Care Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 34: World Intraosseous Infusion Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Intraosseous Infusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Intraosseous Infusion Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Intraosseous Infusion Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Intraosseous Infusion Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030

IV. COMPETITION